ADVENTRX Completes Acquisition of SynthRx
ADVENTRX and SynthRx, a private biotechnology company, completed a definitive merger on April 8, 2011.
Member Spotlight
CeQur Develops Diabetes Compliance Device
An important drawback of current diabetes treatment regimens is patient compliance, particularly for insulin injections that are painful and must also be timely administered.
Accord Biosciences To Present At OneMedForum NY 2011
Nitric oxide is one of the most important physiological signaling molecules in the body, responsible for regulating such fundamental biological processes as proper blood vessel function and the body’s defense against infection.
OneMedForum NY 2011 Grows Its Advisory Board And Selects Initial Presenters
OneMedForum NY 2011, to be held June 23 -24, has added new members to the Advisory Board and selected an initial group of “discovery” lesser known companies with terrific growth potential.
S.E.A. Medical Tackles IV Errors Before They Occur
In 2006, 2-year-old Emily Jerry was killed when a technician mixed her chemotherapy drug with a saline solution 26 times above normal.
ADVENTRX Pharmaceuticals Takes the Next Step In Approval of ANX-530
ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX), with its leading innovations in anti-cancer drug development has just announced that they have been successful in sending their ANX-530 (Exelbine) New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) with a Prescription Drug User Fee Act (PDUFA) date of September 1, 2011.
Northwestern Investigators to Launch 510(k) Survey
Recent controversy surrounding FDA’s processes for premarket review of medical devices has ignited a discussion among researchers in hope of getting to the crux of the issue.
Soft Tissue Regeneration Advancing Next-Generation Device for Common Sports Injury
The cruciate ligaments of the knee are vital for a wide range of activities, from bending over to pick up something on the ground to running bases at a softball game.
OIS’ Subsidiary Named Among Top 20 EMR Software Providers
Abraxas made the list of top 20 ambulatory EMR software vendors for single physician practices, as well as for practices with 2 to 5, 26 to 99, 100 to 249 and 250 or more physicians.
OneMedForum 2011 to Feature “Provider As a System” Panel
“The Provider as a System” will discuss how innovations in information management and technology coupled with changes in the business landscape are transforming the delivery of healthcare.